Global GI Stool Testing Market Size, Status and Forecast 2021-2027

Stools tests are performed to diagnose the GI tract disorders and aid in the detection of parasites infection, bleeding obstruction, and inflammation. Stools tests can further be utilized for diagnosis of colorectal cancer or presence of pathogens such as Rotavirus, C. difficile, H. pylori among others in the GI tract. Laboratory tests used for the stool testing are either microbial particle-based or antibody-based, which include chemiluminescence immunoassays (CLIA), immunoassay and molecular diagnostic testing.
Increased incidence of C. difficile infections and other gastrointestinal diseases increases the demand for stool tests, thereby driving the global GI stool testing market. According to the Centers for Disease Control and Prevention, in 2014, an estimated of 14.8 million adults were diagnosed with ulcers and other digestive disorders in the United States. Furthermore, in 2017, 135,430 new cases of colorectal cancer were diagnosed in the country, raising the demand for GI stool testing. However, the challenge of accurate testing restrains the market.

Market Analysis and Insights: Global GI Stool Testing Market
The global GI Stool Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global GI Stool Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global GI Stool Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global GI Stool Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global GI Stool Testing market.

Global GI Stool Testing Scope and Market Size
GI Stool Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global GI Stool Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Microscopy Tests
Ova & Parasites Test
Occult Blood Test
Stool Biomarkers Tests
Others

Segment by Application
Hospitals
Diagnostics Centers and Laboratories
Research Centers and Academic Institutions

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Clinical Genomics
Diasorin
Meridian Bioscience
Quidel
bioMerieux
Cenogenics
EIKEN CHEMICAL
Helena Laboratories
Hemosure
Quidel
bioMerieux
Pinnacle BioLabs

Frequently Asked Questions